The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Anticardiolipin Antibodies and the Risk for Ischemic Stroke and Venous Thrombosis
Abstract
Objective To determine whether the presence of anticardiolipin antibodies is a risk factor for ischemic stroke and venous thrombosis in healthy adult men. Design A nested, case-control study in a prospective cohort. Setting A nationwide study of physicians. Participants The study sample was drawn from the Physicians' Health Study, a randomized, double-blind, placebo-controlled trial of aspirin and beta-carotene in 22,071 male physicians. At entry, 68% of the participants submitted plasma samples that were subsequently frozen at -80 degrees C. During 60.2 months of follow-up, follow-up for nonfatal outcomes was 99.7% complete and ascertainment of fatal outcomes was 100% complete. We identified men with documented ischemic stroke, deep venous thrombosis of the leg, or pulmonary embolus and for whom a plasma sample was available. A control was matched by age, smoking history, and length of follow-up to each of the 100 patients with ischemic stroke and the 90 patients with deep venous thrombosis or pulmonary embolus. Measurements Plasma samples were assessed for IgG anticardiolipin antibodies by enzyme-linked immunosorbent assay. The mean anticardiolipin antibody titers of the case patients in the two diagnostic groups (ischemic stroke; venous thrombosis or pulmonary embolus) were compared with those of the control groups, and relative risks were calculated for patients in increasing percentile categories of anticardiolipin antibodies by conditional logistic regression. Results T…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Retrospective, [1][2][3][4] case-control [5][6][7][8][9][10][11][12] and cross-sectional 13,14 studies with different designs, patient selection criteria, aPL profiles and risk factors have produced contradictory results.”
From Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study. (2011) · cites this paper as [7]
Citations
Cites
McNeil, H. P., Simpson, R. J., Chesterman, C. N., & Krilis, S. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4120 · Cited by 1,595
Harris, E. N., Boey, M. L., Mackworth-Young, C. G., Gharavi, A. E., Patel, B. M., Loizou, S., & Hughes, G. R. V. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91267-9 · Cited by 1,383
Love, P. E., & Santoro, S. A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-9-682 · Cited by 1,095
The “Primary” Antiphospholipid Syndrome
Asherson, R. A., Khamashta, M. A., Ordi, J., Derksen, R. H. W. M., Machin, S. J., Barquinero, J., OUTT, H. H., Harris, E. N., Vilardell, M., & Hughes, G. R. V. (1989) · Medicine · doi:10.1097/00005792-198911000-00004 · Cited by 963
The "primary" antiphospholipid syndrome: major clinical and serological features.
Asherson, R. A., Khamashta, M. A., Ordi‐Ros, J., Derksen, R. H. W. M., Machin, S. J., Barquinero, J., OUTT, H. H., Harris, E. N., Vilardell, M., & Hughes, G. R. V. (1989) · PubMed · Cited by 892
Alarcón-Segovia, D., Delezé, M., Oria, C. V., Sánchez‐Guerrero, J., Gómez-Pacheco, L., Cabiedes, J., Fernández, L. A. N., & de León, S. P. (1989) · Medicine · doi:10.1097/00005792-198911000-00003 · Cited by 635
Carreras, L., Machin, S. J., Deman, R., DEFREYN, G., Vermylen, J., Spitz, B., & Assche, A. V. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92087-0 · Cited by 551
Loizou, S., McCrea, J. D., Rudge, A. C., Reynolds, R., Boyle, C. C., & Harris, E. N. (1985) · PubMed Central · Cited by 549
Thrombosis, Recurrent Fetal Loss, and Thrombocytopenia
Harris, E. N. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.1986.00360230069012 · Cited by 546
Preliminary Report: Findings from the Aspirin Component of the Ongoing Physicians' Health Study
The Steering Committee of the Physicians' Health Study Research Group (1988) · New England Journal of Medicine · doi:10.1056/nejm198801283180431 · Cited by 522
Research works printed but not linked: 15
- Meyer O, 1987, J Rheum., 14, 502
- Colaco C, 1983, Ann Rheum Dis., 42, 228
- Harris E, 1985, J Clin Lab Immunol., 16, 1
- Colaco C, 1985, Clin Exp Immunol., 59, 449
- Harris E, 1987, Clin Exp Immunol., 68, 215
- Hall S, 1984, J Rheum., 11, 846
- Asherson R, 1989, Q J Med., 73, 1103
- Cronin M, 1988, J Rheum., 15, 795
- Klemp P, 1988, Clin Exp Immunol., 74, 254
- Lavalle C, 1990, J Rheum., 17, 34
- Coon W, 1976, Surg Gynecol Obstet., 143, 385
- Hasselaar P, 1990, J Rheumatol., 17, 186
- Loizou S, 1985, Clin Exp Immunol., 62, 738
- Ruiz-Arguelles G, 1989, J Rheumatol., 16, 381
- McNeil H, 1990, Clin Exp Rheumatol., 8, 525
Cited by
Sorted by citations
Items 401–500 of 525
Sciascia, S., Radin, M., & Schreiber, K. I. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00045-x · Cited by 3
Lupus Anticoagulants: Mechanistic and Diagnostic Considerations
Arnout, J., & Vermylen, J. (2006) · Springer eBooks · doi:10.1007/1-84628-009-5_24 · Cited by 3
Lakos, G. (2013) · Drug Development Research · doi:10.1002/ddr.21117 · Cited by 3
Alba, P. B., Bertolaccini, M. L., & Khamashta, M. A. (2007) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.3.4.613 · Cited by 3
Specker, C. (2006) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-006-0127-3 · Cited by 3
The clinical significance of antiphospholipid antibodies in patients without autoimmune disease
Brighton, T., & Chesterman, C. N. (2000) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.2000.tb04364.x · Cited by 3
Antiphospholipid Antibodies and Associated Clinical Manifestations
Galli, M., Finazzi, G., & Barbui, T. (1996) · Hematology · doi:10.1080/10245332.1996.11746296 · Cited by 3
PHOSPHOLIPID AUTOANTIBODIES: TIME FOR A NEW IMMUNO-ASSAY?
Caso, V., Panarelli, P., Albi, E., Viola‐Magni, M. P., Parnetti, L., & Gallai, V. (2002) · Clinical and Experimental Hypertension · doi:10.1081/ceh-120015327 · Cited by 3
Vermylen, J., Arnout, J., Greaves, M., Pietté, J. C., Biousse, V., Muir, K., Squire, I. B., Alwan, W. H., & Lees, K. R. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91737-x · Cited by 3
Tratamiento del síndrome antifosfolipídico, ¿a quién, cuándo y cuánto tiempo?
Castañeda, M. C. A. (2005) · Reumatología Clínica · doi:10.1016/s1699-258x(05)72773-x · Cited by 2
Ali, H. A., Osman, R. R., Idris, M., & Sokrab, T.-E. O. (2007) · Neurosciences · doi:10.17712/1658-3183.1462 · Cited by 2
Thrombotic antiphospholipid syndrome: Recurrent thromboses
Reshetnyak, T. M., Cheldieva, F. A., Glukhova, S. I., Nurbaeva, K. S., Seredavkina, N. V., Cherkasova, M. V., Lila, A. M., & Nasonov, E. L. (2024) · Rheumatology Science and Practice · doi:10.47360/1995-4484-2024-408-417 · Cited by 2
The (reverse) paradox of lupus anticoagulant: A case report
Kalyani, H., Goyal, M., Banavathu, T., Pandey, S. C., & Rath, P. D. (2024) · Lupus · doi:10.1177/09612033241282058 · Cited by 2
Ha, S. H., Kim, S. U., Huh, J., & Huh, C.-W. (2024) · Medicine · doi:10.1097/md.0000000000039890 · Cited by 2
Thrombotic Antiphospholipid Syndrome: Recurrent Thromboses
Reshetnyak, T. M., Cheldieva, F. A., Glukhova, S. I., Nurbaeva, K. S., Seredavkina, N. V., Cherkasova, M. V., Lila, A. M., & Nasonov, E. L. (2025) · Doklady Biochemistry and Biophysics · doi:10.1134/s1607672925700152 · Cited by 2
Chapter 3 Laboratory Heterogeneity of Antiphospholipid Antibodies
Pierangeli, S. S., & Rand, J. H. (2009) · Technical report · doi:10.1016/s1571-5078(08)00403-0 · Cited by 2
New potential therapies for the treatment of antiphospholipid syndrome
Ak, S., & D’Cruz, D. P. (2009) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770802608048 · Cited by 2
Trombosis protésica en una paciente con síndrome antifosfolípido primario: Caso clínico
García, P. A., G, M. J. M., & Ruiz-Ruano, R. D. L. C. (2010) · Revista médica de Chile · doi:10.4067/s0034-98872010000300011 · Cited by 2
Management of the antiphospholipid syndrome: new approaches
Seif, A. M., Hwang, Y. G., & Pierangeli, S. S. (2009) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.09.43 · Cited by 2
Bokarewa, M. I., & Bremme, K. A. (1998) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1998.tb01056.x · Cited by 2
Aspirin in asymptomatic patients with a confirmed positivity of antiphospholipid antibodies
Basili, S., & Violi, F. (2008) · Internal and Emergency Medicine · doi:10.1007/s11739-008-0193-4 · Cited by 2
Syndrome des antiphospholipides : pourquoi faut-il y penser et comment faire le diagnostic ?
Sibilia, J. (2003) · Revue du Rhumatisme · doi:10.1016/s1169-8330(03)00057-7 · Cited by 2
Diagnosis of antiphospholipid syndrome
Bertolaccini, M. L., & Khamashta, M. A. (2008) · Expert Review of Hematology · doi:10.1586/17474086.1.2.183 · Cited by 2
Clinical Aspects of the Antiphospholipid Syndrome
Lateef, A., & Petri, M. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1893-5.00042-x · Cited by 2
Pathogenesis and Treatment of Atherosclerosis in Lupus
McMahon, M. A., Skaggs, B. J., & Grossman, J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1893-5.00026-1 · Cited by 2
Effendy, S., Tambunan, K. L., & Reksodiputro, A. H. (2005) · PubMed · Cited by 2
Antiphospholipid antibodies: Clinical aspects
Morris, V., & Mackworth‐Young, C. (1996) · Springer eBooks · doi:10.1007/978-94-011-1670-1_42 · Cited by 2
Roubey, R. A. S. (2006) · Elsevier eBooks · doi:10.1016/b978-012595961-2/50033-0 · Cited by 3
Kinuya, K., Kakuda, K., Matano, S., Sato, S., Sugimoto, T., Asakura, H., Kinuya, S., Michigishi, T., & Tonami, N. (2001) · Annals of Nuclear Medicine · doi:10.1007/bf02988501 · Cited by 2
Triplett, D. A. (1999) · Springer eBooks · doi:10.1007/978-94-011-4722-4_19 · Cited by 2
Swan, H. J. C. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-12-1049 · Cited by 2
Management of Thrombosis in the Antiphospholipid Syndrome
Derksen, R. H. W. M., de Groot, P. G., & Brey, R. L. (2002) · Elsevier eBooks · doi:10.1016/b978-044450987-1/50034-6 · Cited by 2
Chapter 19 Future of the Antiphospholipid Syndrome
Kasthuri, R. S., & Roubey, R. A. S. (2009) · Technical report · doi:10.1016/s1571-5078(08)00419-4 · Cited by 1
Chapter 45 Hematological diseases and stroke
Bühler, R., & Mattle, H. P. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(08)93045-1 · Cited by 1
Inflammation, Dyslipidemia And Risks Of Ischemic Strokes In Systemic Lupus Erythematosus
Mikdashi, J. A. (2007) · Future Lipidology · doi:10.2217/17460875.2.5.489 · Cited by 1
¿Se deben tratar preventivamente los pacientes asintomáticos con anticuerpos antifosfolípidos?
Estrada, P., Gómez‐Vaquero, C., Vives, L. L., & Narváez, J. (2012) · Seminarios de la Fundación Española de Reumatología · doi:10.1016/j.semreu.2012.09.001 · Cited by 1
Sato, H., Makoto, M. I. K. I., NAKAYAMA, S., Abé, T., Ohuchi, H., Isawa, T., & Nukiwa, T. (1996) · Respirology · doi:10.1111/j.1440-1843.1996.tb00047.x · Cited by 1
Atteinte cardiaque au cours du syndrome des antiphospholipides
Géri, G., & Cacoub, P. (2011) · La Presse Médicale · doi:10.1016/j.lpm.2011.02.035 · Cited by 1
Laboratory Criteria of Antiphospholipid Syndrome Need to be Updated or Strictly Followed
Martinuzzo, M. E. (2010) · The Open Autoimmunity Journal · Cited by 1
NF. Evaluating Anti β-2 Glycoprotein as Rapid Thromboembolic Marker Among HCV Patients in Egypt
Elkhouly, E. (2013) · American Journal of Life Sciences · doi:10.11648/j.ajls.20130101.11 · Cited by 1
Khamashta, M. A., Pierangeli, S. S., & Harris, E. N. (2011) · Elsevier eBooks · doi:10.1016/b978-0-323-06551-1.00135-4 · Cited by 1
History and Physical Examination in Pulmonary Embolism
Matusov, Y. P., & Tapson, V. F. (2023) · Springer eBooks · doi:10.1007/978-3-030-70904-4_9-1 · Cited by 1
Herrera, R. N., Díaz, E. I., Aguilar, R. C. P., Bianchi, J., Berman, S., & Luciardi, H. L. (2005) · REMERI - Red Mexicana de Repositorios Institucionales · Cited by 1
Nuevas estrategias en el tratamiento del síndrome antifosfolípido
Ibañez, S., Iruretagoyena, M., & GUTIÉRREZ-ESTRADA, M. A. (2013) · Revista médica de Chile · doi:10.4067/s0034-98872013000800011 · Cited by 1
Treatment of "Other" Causes of Stroke
Kasner, S. E. (2004) · Elsevier eBooks · doi:10.1016/b0-44-306600-0/50062-6 · Cited by 1
Treatment of “Other” Stroke Etiologies
Cucchiara, B. L., & Kasner, S. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-69424-7.00058-2 · Cited by 1
Cáliz, R., Fontecha, P. D. D. C., Galindo-Izquierdo, M., Longo, F. J. L., Zamora, M. Á. M., Santamaría, A., Pliego, O. A., Lozano, M. J. C., Beltrán, M. P. D., Ortells, L. C., et al. (2019) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2018.11.012 · Cited by 1
Radoš, J., Dobrić, I., Drvar, D. L., & Lončarić, D. (2005) · PubMed · Cited by 1
Antiphospholipid Syndrome in the Older Population
Pierangeli, S. S., Seif, A. M., & González, E. B. (2011) · Springer eBooks · doi:10.1007/978-1-4419-5792-4_24 · Cited by 1
Andréoli, L., & Tincani, A. (2009) · Internal and Emergency Medicine · doi:10.1007/s11739-008-0222-3 · Cited by 1
Antiphospholipid Syndrome, Microalbuminuria, and Risk of Venous Thromboembolism
Musallam, K. M. (2009) · JAMA · doi:10.1001/jama.2009.1240 · Cited by 1
Novel therapies for the antiphospholipid syndrome
Pierangeli, S. S. (2008) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.4.2.193 · Cited by 1
Prothrombotic states in ischemic stroke
Eby, C. (2002) · Seminars in Cerebrovascular Diseases and Stroke · doi:10.1053/scds.2002.124190 · Cited by 1
The Role of Ultrasound in the Management of Extremity Venous Disease
SINGH, R. S., & Galt, S. W. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-0631-6.50027-0 · Cited by 1
Branch, D. W., & Lockshin, M. (2005) · Technical report · doi:10.1016/s1571-5078(05)04006-7 · Cited by 1
Pulmonary Hypertension and Antiphospholipid Antibodies
Pietté, J. C., & Hunt, B. J. (2006) · Springer eBooks · doi:10.1007/1-84628-009-5_11 · Cited by 1
Roc, M. V., & Olivé, A. (2003) · Piel · doi:10.1016/s0213-9251(03)72673-2 · Cited by 1
Cerebral Ischemia in Antiphospholipid Syndrome
Pattanaik, D., & Brey, R. L. (2006) · Springer eBooks · doi:10.1007/1-84628-009-5_6
Finazzi, G., Marchioli, R., & Barbui, T. (1998) · Springer eBooks · doi:10.1007/978-3-642-80403-8_23
The antiphospholipid syndrome.
Wautrecht, J. C. (2002) · PubMed
PREDICTION OF AUTOIMMUNEITY DISEASES: MITH, REALITY AND RISK
Ortega‐Hernandez, O., López-Guzmán, S., Rojas‐Villarraga, A., & Anaya, J. (2008) · Revista Med
Antiphospholipıd Syndrome and Venous Thrombosis
Okuyan, E. (2012) · InTech eBooks · doi:10.5772/27128
Elimination of axial venous reflux
Oinonen, A. (2009) · Työväentutkimus Vuosikirja
Antiphospholipid Syndrome - An Evolving Story of a Multisystemic Disease
Silvia, S., Willis, R., Harper, B. E., & Manoharan, E. N. E. A. (2012) · InTech eBooks · doi:10.5772/36714
Atherogenesis and Vascular Disease in SLE
Ferreira, I., & Delgado, J. (2012) · InTech eBooks · doi:10.5772/26028
Hereditary and acquired thrombophilia in pregnancy
Bick, R. L., & Baker, W. (2006) · Cambridge University Press eBooks · doi:10.1017/cbo9780511526978.006
Le bilan biologique de thrombose veineuse
Alhenc‐Gelas, M., & Aiach, M. (2001) · Bio Tribune Magazine · doi:10.1007/bf03010268
Lupus, syndrome des antiphospholipides et épilepsie
Arnaud, L., & Amoura, Z. (2010) · Epilepsies · doi:10.1684/epi.2010.0345
Inherited thrombophilia and early pregnancy
Middeldorp, S. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511777851.015
Recent trends in venous thrombosis and pulmonary embolism.
Newman, J. H. (1997) · PubMed Central
Antiphospholipid antibodies and lipoprotein(a) in obese children
Pascut, D., Princi, T., Donato, M., Tamaro, G., & Parco, S. (2009) · Acta Paediatrica · doi:10.1111/j.1651-2227.2008.01182.x
Gastroenterological manifestations of antiphospholipid syndrome
Gatenby, P. A. (1997) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1997.tb00379.x
Rocha, L. K. A., Galante, N. Z., Alvarez, V. A. C., Areco, K. C. N., Noguti, M. A. E., Amaral, R. Q., Andrade, L. E. C., Peres, C. A., Pestana, J. O. M., & Lourenço, D. M. (2009) · Brazilian Journal of Nephrology · doi:10.1590/s0101-28002009000400006
Role of anti-prothrombin in antiphospholipid syndrome
Cinquini, M., Vianelli, M., Allegri, F., Cattaneo, R., Balestrieri, G., & Tincani, A. (2011) · Reumatismo · doi:10.4081/reumatismo.2002.243
Singh, R., Cuchacovich, R., Huang, W., Menon, Y., & Espinoza, L. R. (2002) · JCR Journal of Clinical Rheumatology · doi:10.1097/00124743-200206000-00018
Diagnostic biologique des anticorps dits anticardiolipine: peut-on envisager une standardisation?
Reber, G., Boehlen, F., & de Moerloose, P. (1997) · Revue Française des Laboratoires · doi:10.1016/s0338-9898(97)80149-7
Re: Anticardiolipin Antibodies Are Not an Independent Risk Factor for Stroke
Sargeant, L. A., Kahwa, E., & Wilks, R. (2001) · Stroke · doi:10.1161/01.str.32.5.1234-c
Corthell, L. S. (2007) · D-Scholarship@Pitt (University of Pittsburgh)
The future of treatment for antiphospholipid syndrome
Willis, R., Harris, E. N., & Pierangeli, S. S. (2014) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.13.73
Arterial thrombosis in the antiphospholipid syndrome
Urbanus, R. T. (2008) · Utrecht University Repository (Utrecht University)
Síndrome de antifosfolípidos. Caso clínico y revisión de la bibliografía
González, J., Silva, J. A. V., Tatz, B. T., & Sánchez, J. S. A. (2006) · Medicina Interna de México
Hinchey, J. A., Howard, V. J., Jauch, E. C., Levine, S. R., Meschia, J. F., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., Hart, R. G., et al. (2012)
Meschia, J. F., Moore, W. S., Pearson, T. A., Hart, R. G., Hinchey, J. A., Howard, V. J., Jauch, E. C., Chaturvedi, S., Creager, M. A., Culebras, A., et al. (2010)
Clinical Studies Examining Thrombosis Related to Autoimmune Antiphospholipid Antibodies
Bertolaccini, M. L., & Khamashta, M. A. (2010) · The Open Autoimmunity Journal
T HE A NTIPHOSPHOLIPID S YNDROME
Evine, S. L., Are, D. W., Ranch, B., & Auch, J. O. R. (2002)
Meschia, J. F., Moore, W. S., Hart, G. L. W., Hinchey, J. A., Howard, V. J., Jauch, E. C., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., et al. (2011)
Task Force Report on “Non-criteria” Antiphospholipid Antibody Tests
Bertolaccini, M. L., Amengual, O., Atsumi, T., Binder, W. L., Kutteh, W. H., de Laat, B., Forastiero, R. R., Lambert, M., Matsubayashi, H., Murthy, V. L., et al. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3194-7_8
Patent foramen ovale and cryptogenic brain infarction
Karttunen, V. (2002)
Antiphospholipid Antibody Syndrome
Kok-Yong, F., & Mee-Leng, B. (1996) · BioDrugs · doi:10.1007/bf03259521
Rothschild, B. M., & Originale, L. (2004)
Treatment of “Other” Stroke Etiologies
Kasner, S. E., & Cucchiara, B. L. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5478-8.10054-5
The Role of Anti-Phospholipid Auto Antibodies Syndrome in Cerebrovascular Diseases
Ali, H., & Abdullah, Z. A. (2007) · Qatar medical journal · doi:10.5339/qmj.2007.2.15
Clinical Presentation of Antiphospholipid Syndrome
Khamashta, M. A. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-374994-9.10053-1
Laboratory Testing for Antiphospholipid Syndrome
Ioannou, Y., & Krilis, S. A. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-374994-9.10052-x
Risk Factors and the Role of Ultrasound in the Management of Extremity Venous Disease
Polak, J. F., & Pellerito, J. S. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1417-3.00020-6
Medical Problems Affecting Stroke Rehabilitation
Roth, E. J., & Green, D. (1996) · Topics in Stroke Rehabilitation · doi:10.1080/10749357.1996.11754095
Eular On-line Course on Rheumatic Diseases - module n°19
Khamashta, M. A., Bertolaccini, M. L., & Østensen, M. (2008)
Childhood Cerebrovascular Disease
Vossough, A., & Zimmermann, R. A. (2016) · Springer eBooks · doi:10.1007/978-3-662-46258-4_13-1
Prognosis in Antiphospholipid Syndrome
Serrano, R. M., Pons‐Estel, G., Espinosa, G., & Cervera, R. (2016) · Technical report · doi:10.1016/b978-0-444-63655-3.00019-3
Metadata
- Authors
- Ginsburg, K. S., Liang, M. H., Newcomer, L., Goldhaber, S. Z., Schur, P. H., Hennekens, C. H., & Stampfer, M. J.
- Affiliations
- Brigham and Women's Hospital (US)
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1992-12-15
- Volume
- 117
- Issue
- 12
- Pages
- 997-1002
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W1491481195
- Cited by
- 526
- References
- 49
- Citations by year
- 2025: 2 · 2024: 7 · 2023: 5 · 2022: 1 · 2021: 8 · 2020: 8 · 2019: 4 · 2018: 3 · 2017: 6 · 2016: 7 · 2015: 7 · 2014: 10 · 2013: 15 · 2012: 16
- FWCI
- 16.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01CA042182, CA 42182)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (P60AR036308, AR-36308, AR-07530, T32AR007530)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- anticardiolipin antibodies, ischemic stroke, venous thrombosis, deep vein thrombosis, pulmonary embolism, thrombophilia, risk factors, IgG, male physicians, Physicians' Health Study, aspirin, beta-carotene, anticoagulation, stroke prevention, antithrombotic therapy
- MeSH terms
- Adult, Aged, Aged, 80 and over, Brain Ischemia, Enzyme-Linked Immunosorbent Assay, Humans, Male, Middle Aged, Prospective Studies, Pulmonary Embolism, Risk Factors, Statistics as Topic, Thrombophlebitis, Case-Control Studies, Antibodies, Anticardiolipin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review